Drawing for MDSP

USPTO serial 78078185

MDSP

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SMIGA, HOWARD
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MDSP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donna M. Weinstein, Esq.

DONNA M WEINSTEIN FOLEY, HOAG & ELIOT LLP1 POST OFFICE SQBOSTON, MA 02109-2106UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Systems and computer programs for assays in the diagnosis of diseases; systems and computer programs for chemical markers for disease states; systems and computer programs for performing diagnostics for diseases; systems and computer programs for determining targets for drugs; systems and computer programs for determining protein and peptide sequences; and scientific instruments, namely, mass spectrometers, automated sample preparers for mass spectrometers, and part and accessories for the foregoing, all for developing assays for the diagnosis of diseases, developing chemical markers for disease states, performing diagnostics for diseases, determining targets for drugs, and determining protein and peptide sequences.ACTIVE—
042Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 12, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 12, 2002DOCKASSIGNED TO EXAMINER—
Oct 11, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance